Coronary artery disease occurring with protease inhibitor therapy

International Journal of STD and AIDS

Volumn 9, Issue 11, 1998, Pages 711-712

  Sullivan, A K ^a   Nelson, M R ^a   Moyle, G J ^a   Newell, A M ^a   Feher, M D ^a   Gazzard, B G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Hyperlipidaemia; Protease inhibitors

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

ADULT; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LIPIDS; MALE; MIDDLE AGED;

EID: 0031732735     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981921251     Document Type: Article

References (4)

1. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-F58
2. Sullivan AK, Nelson MR. Marked hyperlipidaemia on ritonavir therapy. AIDS 1997;11:938-9
3. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328
4. Shaper AG, Cook DG, Walker M, Macfarlane PW. Prevalence of ischaemic heart disease in middle aged British men. Br Heart J 1984;51:595-605